from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3481c/-

LFCtreatmentdescriptionclass of inhibitor

0.468

Amikacinug/mL Amikacintranslation

0.548

Cap5-10ug/mL Capreomycintranslation

0.586

Rox10-50 ug/mL Roxithromycintranslation

0.331

SM2-5 ug/mL Streptomycintranslation

-0.983

Tet5-10 ug/mL Tetracyclinetranslation

1.137

Rif0.2-5ug/mL Rifampicintranscription

0.374

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.244

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.254

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.734

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.185

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.306

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.953

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.615

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.453

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.584

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.520

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.067

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.074

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.402

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.845

KCN5-20 ug/mL Potassium cyaniderespiration

-1.581

NaN30.2-2 mM Sodium aziderespiration

0.313

Nigericin50 uM Nigericinrespiration

0.014

TRC10-150 ug/mL Triclosanrespiration

-1.557

TRZ10-25 ug/mL Thioridazinerespiration

-0.390

Valinomycin0.5-10 uM Valinomycinrespiration

0.339

ZnSO42 mM ZnSO4respiration

0.247

menadione6-10 ug/mL Menadionerespiration

-0.340

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.459

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.108

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.304

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.356

NRP_1Non-replicating persistence stage 1dosRassociated

0.492

Amp0.2mg/mL AmpicillincellWall

0.202

Cephalexin20-100 ug/mL CephalexincellWall

0.255

Cerulenin0.32-5 ug/mL CerulenincellWall

0.815

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.491

EMB10-20 ug/mL EthambutolcellWall

0.466

Eta12-40 ug/mL EthionamidecellWall

0.441

INH0.2-0.4 ug/mL IsoniazidcellWall

0.062

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.035

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.139

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.038

BZA0.12 mg/mL BenzamidearomaticAmides

1.098

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.362

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.032

H2O24 mM hydrogen peroxideDNAdamaging

0.430

Levo10 ug/mL LevofloxacinDNAdamaging

0.615

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.197

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.192

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.349

UVUV-irradiationDNAdamaging

-1.077

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.029

Antimycin12.5-50 ug/mL Antimycin A?

0.388

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.532

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.245

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.287

PA8240.2-2 ug/mL PA-824?

-0.730

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.084

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.390

Verapamil50 uM Verapamil?

-0.134

mercaptoethanol2 mM 2-Mercaptoethanol?

0.223

methoxatin10-20 ug/mL Methoxatin?